SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Jun-24 6:14 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 12,220 | -- | -- | 31% 39.65K to 51.87K | |
05-Jun-24 5:09 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 2,979 | $30.89 | $92,021.30 | (7%) 42.63K to 39.65K | |
07-Jun-23 9:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,371 | $37.87 | $51,912.90 | (4%) 35.0K to 33.63K | |
07-Jun-23 9:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,236 | $38.99 | $48,192.90 | (3%) 36.23K to 35.0K | |
08-Jun-22 7:41 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 7,950 | -- | -- | 28% 28.28K to 36.23K | |
08-Jun-22 7:41 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 2,516 | $61.37 | $154,417.00 | (8%) 30.8K to 28.28K | < 1% |
11-Jun-21 8:40 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 6,000 | -- | -- | 24% 24.8K to 30.8K | |
08-Jun-21 4:17 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale | 2,648 | $61.04 | $161,626.00 | (10%) 27.45K to 24.8K | (1%) |
11-Jun-20 6:32 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 12,600 | -- | -- | 85% 14.85K to 27.45K | |
08-Jun-20 9:07 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-20 | Market Sale | 1,489 | $46.33 | $68,986.90 | (9%) 16.34K to 14.85K | (28%) |
06-Jun-19 4:55 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 4,400 | -- | -- | 37% 11.94K to 16.34K | |
06-Jun-19 4:55 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-19 | Market Sale | 1,106 | $42.91 | $47,458.50 | (8%) 13.04K to 11.94K | (38%) |
15-Jun-18 7:19 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-18 | Grant | 5,000 | -- | -- | 62% 8.04K to 13.04K | |
06-Jun-18 8:08 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-18 | Market Sale | 708 | $33.02 | $23,378.20 | (8%) 8.75K to 8.04K | (79%) |
16-Jun-17 8:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jun-17 | Grant | 8,750 | -- | -- | 100% 0 to 8.75K |